Audio Interviews

ValueTheMarkets Podcast 033 – with Ray Barlow, CEO of E-Therapeutics (ETX)

25 Nov 2019 | by: Patricia Miller

Today’s guest on the ValueTheMarkets podcast is Dr Ray Barlow, CEO of E-Therapeutics (LSE:ETX). The company is employing a computer-based approach to the discovery of new drugs. It’s Network-Driven Discovery (NDD) platform employs techniques such as machine learning, artificial intelligence, and data analysis to find better drug solutions in a more efficient manner.

In the interview, Ray discusses the NDD platform, the company’s business model, the changes he’s made since joining the board in 2017, and talks about his background in the industry., Digitonic Ltd (and our owners, directors, officers, managers, employees, affiliates, agents and assigns) are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

  • Digitonic Ltd, the owner of, has been paid for the production this piece by the company or companies mentioned above.

RNS Responses

What is an alternative investment?

Alternative investments cover everything from venture capital and commodities to stamps, antiques and even whisky. Find out more in our ‘What is..?’ series.

Squarespace IPO: what you need to know

Squarespace $SQSP is heading for a direct listing this month. Does this tech savvy web hosting service look a good long-term investment or a stock to avoid?

Are there any ESG friendly cryptos?

Environmental, Social, and Corporate Governance (ESG) investing is forcing agendas. Will Tesla backing out of accepting Bitcoin hinder crypto’s rise?